Tokyo, Jan. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060284) titled 'Survey on the burden of sialorrhea symptoms in patients with parkinson's disease' on Jan. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Other
Condition:
Condition - Parkinson's disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the comparative impact of sialorrhea against other motor symptoms (MS) and non-motor symptoms (NMS) on the daily functioning of patients with parkinson's disease (PD)
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients affiliated with PD patient organizations (specifically, the Kibou-no-kai for Young-Onset Parkinson's Disease and the Japan Parkinson's Disease Association)
2) Patients diagnosed with PD at least one month prior to the survey
3) Individuals aged 18 years or older, regardless of gender
4) Patients capable of self-completing the survey (assistance from a caregiver for input is permissible)
5) Patients able to provide voluntary informed consent for participation in this study
Key exclusion criteria - Patients currently participating in any interventional clinical trial
Target Size - 1400
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 11 Month 07 Day
Date of IRB - 2025 Year 11 Month 20 Day
Anticipated trial start date - 2026 Year 02 Month 28 Day
Last follow-up date - 2026 Year 04 Month 03 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068963
Disclaimer: Curated by HT Syndication.
